Form S-3 BIORA THERAPEUTICS, INC.

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to Form S-3 BIORA THERAPEUTICS, INC.

Biora Therapeutics (BIOR) PT Lowered to $15 at H.C. Wainwright

April 9, 2024 6:37 AM EDT

H.C. Wainwright analyst Joseph Pantginis lowered the price target on Biora Therapeutics (NASDAQ: BIOR) to $15.00 (from $50.00) while maintaining a Buy rating.

The analyst comments "Initial SAD data reaffirm NaviCap's MoA and fruther de-risk upcoming clinical readouts. During 2023, Biora made significant headway advancing its two leading drug delivery devices: Biojet and NaviCap. The BioJet made considerable progress in preclinical evaluations; data readouts using BioJet is anticipated throughout 2024. Moreover, NaviCap... More